tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
Advertisement

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Similar Stocks

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$5.23
HK$16.97B
17.60
29.78%
0 Buy
0 Hold
1 Sell
Moderate Sell
HUTCHMED (China)
HK$23.76
£20.72B
5.70
-27.78%
2 Buy
0 Hold
1 Sell
Moderate Buy
Shanghai Fosun Pharmaceutical (Group) Co
HK$23.76
HK$79.38B
18.09
68.00%
1 Buy
1 Hold
0 Sell
Moderate Buy
China Resources Pharmaceutical Group Ltd.
HK$4.74
€29.78B
9.79
-15.88%
CanSino Biologics, Inc. Class H
HK$43.38
HK$13.15B
73.17%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
5.23
1.24
31.08%
HK:0013
HUTCHMED (China)
23.76
-9.14
-27.78%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
23.76
9.70
68.93%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.74
-0.97
-17.03%
HK:1558
HK:6185
CanSino Biologics, Inc. Class H
43.38
18.53
74.57%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis